publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
person
use
reproduc
permiss
lancet
articl
background
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
associ
newli
discov
coronaviru
sarsassoci
coronaviru
sarscov
clinic
experiment
studi
assess
role
viru
caus
sar
method
test
clinic
postmortem
sampl
sar
patient
six
countri
infect
sarscov
human
metapneumoviru
respiratori
pathogen
infect
four
cynomolgu
macaqu
macaca
fasciculari
sarscov
attempt
replic
sar
necropsi
day
infect
find
sarscov
infect
diagnos
patient
fit
case
definit
sar
human
metapneumoviru
diagnos
respiratori
pathogen
diagnos
sporad
sarscov
therefor
like
causal
agent
sar
four
sarscovinfect
macaqu
excret
sarscov
nose
mouth
pharynx
day
infect
three
four
macaqu
develop
diffus
alveolar
damag
similar
sar
patient
characteris
epitheli
necrosi
serosanguin
exud
format
hyalin
membran
type
pneumocyt
hyperplasia
presenc
syncytia
sarscov
detect
pneumon
area
viru
isol
rtpcr
localis
alveolar
epitheli
cell
syncytia
immunohistochemistri
transmiss
electron
microscopi
interpret
replic
sarscovinfect
macaqu
pneumonia
similar
human
be
sar
combin
high
preval
sarscov
infect
sar
patient
fulfil
criteria
requir
prove
sarscov
primari
caus
sar
sever
acut
respiratori
syndrom
sar
emerg
diseas
first
report
guangdong
provinc
peopl
republ
china
novemb
spread
asian
countri
north
america
europ
juli
epidem
result
global
report
case
fatal
pulmonari
lesion
sar
patient
diagnos
diffus
alveolar
damag
histolog
chang
includ
desquam
pneumocyt
format
hyalin
membran
flood
alveolar
lumina
oedema
fluid
mix
inflammatori
cell
presenc
enlarg
pneumocyt
syncytia
alveolar
wall
thicken
mild
mononuclear
infiltr
later
stage
air
space
contain
fibromyxoidorganis
exud
coronaviruslik
particl
detect
transmiss
electron
microscopi
cell
lung
biopsi
sampl
bronchoalveolar
lavag
sampl
pneumocyt
postmortem
lung
sampl
immunohistochem
detect
sarsassoci
coronaviru
sarscov
sarsassoci
lesion
succeed
identif
causal
agent
sar
essenti
make
accur
case
definit
diagnos
diseas
accur
develop
appropri
prevent
cur
treatment
sever
agent
propos
cours
investig
sar
initi
investig
china
mycoplasma
pneumonia
chlamydia
sp
suggest
possibl
caus
subsequ
studi
rule
agent
known
viral
bacteri
pathogen
except
human
metapneumoviru
previoulsi
unknown
coronaviru
identifi
patient
sar
suggest
coronaviru
alon
combin
human
metapneumoviru
causal
agent
might
primari
caus
sar
investig
causal
role
newli
discov
sarscov
analysi
result
investig
done
network
laboratori
show
sarscov
agent
seen
consist
patient
probabl
sar
also
investig
whether
respiratori
lesion
sar
could
replic
experiment
infect
cynomolgu
macaqu
macaca
fasciculari
replic
base
histopatholog
preliminari
report
localis
sarscov
typic
pulmonari
lesion
immunohistochemistri
transmiss
electron
microscopi
newli
discov
coronaviru
primari
caus
sever
acut
respiratori
syndrom
patient
studi
fit
case
definit
sar
tabl
data
variou
proport
patient
cohort
publish
previous
antibodi
sarscov
detect
pair
acut
convalesc
sera
use
indirect
immunofluoresc
assay
patient
cohort
addit
enzymelink
immunosorb
assay
use
minor
modif
cohort
antibodi
human
metapneumoviru
detect
pair
acut
convalesc
sera
use
immunofluoresc
assay
humanmetapneumovirusinfect
fetal
rhesu
monkey
kidney
cell
patient
cohort
patient
humanmetapneumoviru
cultur
posit
cohort
igaspecif
iggspecif
eia
use
remain
five
patient
cohort
patient
cohort
igaspecif
eia
use
patient
cohort
test
develop
commerci
distribut
medden
diagnost
vorden
netherland
clinic
sampl
rna
extract
obtain
vari
among
cohort
includ
swab
nose
pharynx
conjunctiva
aspir
nasopharynx
trachea
bronchoalveolar
lavag
fluid
faec
urin
sputum
blood
sampl
includ
postmortem
lung
tissu
cohort
variou
organ
cohort
rtpcr
sarscov
clinic
sampl
done
accord
peiri
colleagu
method
cohort
accord
drosten
colleagu
cohort
compar
test
use
primer
pair
use
cohort
primer
pair
cohort
primer
pair
cohort
viru
isol
procedur
sarscov
done
inocul
sampl
vero
cell
cohort
hela
human
embryon
lung
llc
madindarbi
canin
kidney
cell
vero
cell
line
cohort
presenc
viru
confirm
immunofluoresc
rtpcr
rtpcr
human
metapneumoviru
clinic
sampl
done
accord
peiri
colleagu
method
cohort
use
primer
pair
cohort
accord
method
peret
colleagu
convent
realtim
pcr
cohort
use
familyspecif
primer
pair
accord
drosten
colleagu
cohort
cohort
use
n
f
genebas
primer
nest
pcr
use
outer
primer
pair
inner
primer
pair
cohort
addit
cohort
sampl
inocul
onto
hela
human
embryon
lung
llc
madindarbi
canin
kidney
vero
cell
line
day
cohort
nasopharyng
aspir
sampl
inocul
onto
rhesu
monkey
kidney
cell
human
laryng
carcinoma
cell
monolay
incub
day
cell
day
cell
roller
tube
cultur
system
cell
line
select
base
result
initi
assess
irrespect
presenc
cytopath
effect
cell
cultur
supernat
testd
human
metapneumoviru
nest
rtpcr
use
outer
primer
pair
ra
g
yc
inner
primer
pair
pcr
product
confirm
nucleotid
sequenc
addit
cell
cultur
posit
human
metapneumoviru
rtpcr
passag
anoth
rhesu
monkey
kidney
cell
cultur
tube
incub
day
randomli
select
supernat
cell
cultur
cyopath
effect
examin
electron
microscopi
presenc
viru
particl
made
viru
stock
use
inocul
cynomolgu
macaqu
fourth
passag
sarscov
isol
obtain
patient
die
sar
inocul
vero
cell
cultur
iscov
modifi
dulbeco
medium
bio
whitak
walkersvil
md
usa
centrifug
g
min
ml
sampl
made
supernat
pellet
cell
resuspend
ml
medium
titr
viru
stock
median
tissu
cultur
infecti
dose
tcid
per
ml
cell
cultur
done
biosafeti
level
condit
four
adult
cynomolgu
macaqu
two
male
two
femal
place
neg
pressuris
glove
box
infect
tcid
sarscov
suspend
ml
phosphatebuff
salin
ml
appli
intratrach
ml
intranas
ml
conjunctiva
check
macaqu
daili
clinic
sign
infect
day
infect
anaesthetis
macaqu
ketamin
collect
ml
blood
inguin
vein
took
nasal
oral
pharyng
rectal
swab
place
ml
viru
transport
medium
macaqu
also
collect
sputum
sampl
use
swab
tongu
spong
place
buccal
caviti
anaesthesia
extract
fluid
spong
centrifug
macaqu
euthanis
day
infect
exsanguin
ketamin
anesthesia
necropsi
macaqu
accord
standard
protocol
histolog
examin
collect
follow
tissu
adren
gland
aorta
axillari
lymph
node
brachial
bicep
muscl
brain
stem
caecum
cerebellum
cerebrum
colon
duodenum
eye
tissu
lightmicroscop
examin
fix
neutralbuff
formalin
embed
paraffin
section
stain
haematoxylin
eosin
select
lung
section
stain
monoclon
antibodi
neomark
fremont
ca
usa
identif
epitheli
cell
monoclon
antibodi
dako
glostrup
denmark
identif
macrophag
accord
standard
immunohistochem
procedur
develop
immunohistochem
method
detect
sarscov
antigen
duplic
section
tissu
sampl
stain
avidinbiotin
complex
peroxidas
method
paraffin
remov
section
rehydr
pretreat
proteas
sigma
st
loui
mo
usa
min
endogen
peroxidas
reveal
sigma
endogen
biotin
block
avidinbiotin
block
kit
vector
laboratori
burlingam
ca
usa
slide
briefli
wash
phosphatebuff
salin
tween
fluka
buch
switzerland
incub
biotinyl
purifi
human
igg
convalesc
sar
patient
neg
control
biotinyl
purifi
human
igg
dilut
buffer
phosphatebuff
salin
contain
bovin
serum
albumin
h
room
temperatur
wash
section
incub
avidinbiotin
complexhorseradish
peroxidas
dako
h
room
temperatur
horseradish
peroxidas
activ
reveal
incub
slide
sigma
solut
min
result
bright
red
precipit
section
counterstain
haematoxylin
tissu
section
cynomolgu
macaqu
infect
sarscov
includ
neg
control
includ
formalinfix
paraffinembed
sarscovinfect
uninfect
vero
cell
stain
posit
neg
control
respect
neg
contrast
electron
microscopi
sampl
tissu
cultur
supernat
centrifug
g
pellet
resuspend
phosphatebuff
salin
stain
phosphotungst
acid
sampl
lung
macaqu
fix
transmiss
electron
microscopi
formaldehyd
glutar
di
aldehyd
brief
fixat
neutralbuff
formalin
postfix
osmium
tetroxid
embed
epoxi
resin
thin
section
prepar
stain
satur
uranyl
acet
lead
citrat
examin
philip
morgagni
electron
microscop
sampl
lung
duodenum
jejunum
kidney
liver
spleen
collect
post
mortem
viru
isol
rtpcr
addit
collect
follow
sampl
rtpcr
cerebellum
cerebrum
ileum
intestin
content
colon
mesenter
lymph
node
nasal
septum
pancrea
skin
spleen
stomach
tonsil
trachea
tracheobronchi
lymph
node
urinari
bladder
urin
macaqu
sampl
intestin
content
jejunum
ileum
caecum
also
collect
rtpcr
intestin
content
pretreat
stool
transport
recoveri
buffer
roch
diagnost
mannheim
germani
process
tissu
sampl
homogenis
ml
transport
medium
polytron
tissu
grinder
kinematica
littaulucern
switzerland
lowspe
centrifug
homogen
frozen
inocul
vero
cell
cultur
logarithm
dilut
infecti
viru
titr
express
tcid
g
tissu
ident
isol
viru
confirm
sarscov
rtpcr
supernat
develop
rtpcr
primer
probe
specif
nucleoprotein
gene
sarscov
natur
coronaviru
replic
cycl
suggest
assay
may
sensit
rtpcr
base
polymeras
gene
current
use
diagnost
nucleic
acid
isol
done
magnapur
lc
autom
nucleic
acid
isol
system
roch
diagnost
swab
faec
serum
process
magnapur
lc
total
nucleic
acid
serum
plasma
blood
isol
kit
postmortem
tissu
sampl
process
magnapur
lc
rna
isol
kit
magnapur
lc
station
use
extern
lysi
protocol
sarscov
rna
detect
abi
prism
use
ez
rtth
rna
amplif
kit
appli
biosystem
foster
citi
ca
usa
primer
sarsnp
sarsnp
probe
sarsnp
eurogentec
specif
nucleoprotein
np
gene
sarscov
use
amplif
amplif
paramet
min
min
min
cycl
min
compar
sensit
sarscov
np
rtpcr
sarscov
polymeras
rtpcr
use
essenti
method
primer
probe
specif
sarscov
polymeras
sarstm
serial
dilut
sarscov
viru
stock
sarscovinfect
vero
cell
patient
made
test
np
polymerasespecif
rtpcr
sampl
respiratori
tract
nasal
swab
pharyng
swab
postmortem
trachea
lung
sampl
also
monitor
influenza
b
viru
respiratori
syncyti
viru
b
rhinoviru
coronaviru
human
metapneumoviru
use
essenti
rtpcr
method
specif
primer
detect
antibodi
sarscov
macaqu
sera
use
indirect
immunofluoresc
assay
sarscovinfect
vero
cell
develop
cytopath
effect
use
coat
microscop
slide
incub
serum
min
slide
wash
phosphatebuff
salin
incub
antihuman
igg
iga
igm
conjug
fluorescein
thiocyan
dako
wash
dri
slide
examin
fluoresc
microscop
zeiss
axioscop
oberkochen
germani
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
overal
patient
suspect
sar
accord
case
definit
diagnos
infect
probabl
sarscov
wherea
diagnos
human
metapneumoviru
infect
tabl
high
proport
patient
diagnos
human
metapneumoviru
infect
could
attribut
mainli
cohort
patient
posit
infect
without
cohort
overal
proport
human
metapneumoviru
diagnos
decreas
altern
diagnos
patient
test
neg
sarscov
infect
influenza
five
pneumonia
infect
one
legionella
sp
infect
one
three
macaqu
becam
letharg
day
infect
onward
macaqu
develop
temporari
skin
rash
day
infect
macaqu
respiratori
distress
consist
increas
respiratori
rate
dyspnoa
day
infect
onward
macaqu
multipl
foci
pulmonari
consolid
lung
consolid
lung
tissu
greyr
firm
level
less
buoyant
normal
tracheobronchi
lymph
node
spleen
macaqu
twice
normal
size
organ
three
macaqu
well
respiratori
tract
organ
macaqu
normal
microscop
inspect
main
lesion
consolid
pulmonari
tissu
macaqu
involv
alveoli
bronchiol
consist
area
acut
advanc
phase
diffus
alveolar
damag
area
lumina
alveoli
bronchiol
variabl
fill
proteinrich
oedema
fluid
fibrin
erythrocyt
cellular
debri
moder
number
alveolar
macrophag
fewer
neutrophil
lymphocyt
figur
cytoplasm
macrophag
contain
erythrocyt
pool
oedema
fluid
extens
loss
epithelium
alveolar
bronchiolar
wall
area
advanc
diffus
alveolar
damag
alveolar
wall
moder
thicken
line
cuboid
epitheli
cell
type
pneumocyt
hyperplasia
alveolar
lumina
contain
mainli
alveolar
macrophag
figur
regener
epithelium
seen
bronchiol
visibl
one
irregular
layer
squamou
high
cuboid
epitheli
cell
hyperchromat
nuclei
area
alveolar
wall
line
deep
eosinophil
hyalin
membran
figur
occasion
multinucl
giant
cell
syncytia
bronchiol
alveoli
either
attach
wall
free
lumen
figur
syncytia
peripher
nuclei
abund
hyalin
eosinophil
cytoplasm
base
posit
stain
neg
pankeratin
stain
origin
marcophag
enlarg
type
pneumocyt
larg
vacuol
nuclei
promin
nucleoli
abund
vesicular
cytoplasm
frequent
found
attach
alveolar
wall
figur
epitheli
origin
cell
confirm
keratin
express
figur
contrast
alveolar
macrophag
smaller
nuclei
less
promin
nucleoli
gener
loos
alveolar
lumina
figur
ident
cell
macrophag
confirm
stain
figur
alveolar
bronchiolar
wall
thicken
oedema
fluid
mononuclear
cell
neutrophil
aggreg
lymphocyt
around
small
pulmonari
vessel
moder
number
lymphocyt
macrophag
present
lamina
propria
submucosa
bronchial
wall
neutrophil
bronchial
epithelium
chang
tissu
macaqu
diffus
lymphoid
hyperplasia
sinu
histiocytosi
tracheobronchi
lymph
node
macaqu
also
diffus
intrafollicular
hyalinosi
spleen
minimum
multifoc
inflammatori
lesion
pulmonari
tissu
macaqu
consist
increas
number
alveolar
macrophag
ten
per
alveolu
occasion
syncytia
alveoli
bronchiol
use
biotinyl
igg
fraction
sar
patient
sarscov
express
detect
moder
number
alveolar
epitheli
cell
type
pneumocyt
figur
rare
intrabronchiolar
intraalveolar
syncytia
ultrastructur
coronaviruslik
particl
measur
nm
diamet
typic
intern
nucleocapsidlik
structur
clubshap
surfac
project
found
enlarg
alveolar
epitheli
cell
type
pneumocyt
inflam
lung
tissu
macaqu
particl
localis
within
smoothwal
vesicl
often
close
associ
golgi
apparatu
figur
particl
inflam
lung
tissu
similar
size
structur
coronaviru
particl
vero
cell
infect
sarscov
figur
npspecif
rtpcr
sensit
polymerasegenebas
rtpcr
viru
stock
infect
cell
dilut
seri
np
rtpcr
also
sensit
base
detect
viral
rna
sampl
obtain
sarscovinfect
macaqu
data
shown
macaqu
shed
sarscov
sputum
nose
pharynx
day
infect
onward
tabl
sarscov
isol
nasal
throat
swab
macaqu
day
infect
throat
swab
macaqu
day
infect
sputum
sampl
macaqu
day
infect
viru
titr
sampl
measur
sever
clinic
sampl
posit
rtpcr
tabl
negativecontrast
electron
microscopi
coronaviru
particl
seen
cell
cultur
obtain
nasal
swab
figur
close
resembl
viru
stock
use
infect
macaqu
figur
viru
detect
rectal
swab
sarscov
isol
lung
tcid
g
tissu
kidney
tcid
g
tissu
macaqu
lung
tcid
g
tissu
macaqu
viru
isol
postmortem
sampl
macaqu
sever
tissu
posit
rtpcr
tabl
macaqu
detect
antibodi
sarscov
day
infect
virolog
examin
nasal
pharyng
swab
tracheal
lung
sampl
four
macaqu
rtpcr
influenza
b
viru
respiratori
syncyti
viru
b
rhinoviru
coronaviru
human
metapneumoviru
neg
relev
pathogen
identifi
bacteriolog
cultur
lung
blood
sampl
lung
homogen
test
neg
chlamydia
sp
c
pneumonia
pcr
accord
koch
postul
modifi
river
viru
diseas
six
criteria
need
fulfil
particular
microorgan
causal
agent
diseas
laboratori
investig
clinic
postmortem
sampl
sar
patient
present
earlier
studi
alreadi
fulfil
first
three
criteriaisol
viru
diseas
host
cultiv
experiment
host
host
cell
proof
filter
exclud
larger
pathogen
result
studi
sarscovinfect
macaqu
fulfil
remain
postulatesproduct
compar
diseas
origin
host
relat
speci
reisol
viru
detect
specif
immun
respons
viru
experiment
infect
alreadi
report
togeth
find
prove
sarscov
primari
caus
sar
primari
role
sarscov
caus
sar
suggest
cumul
studi
laboratori
sar
patient
diagnos
sarscov
infect
frequent
absenc
respiratori
pathogen
common
coinfect
sar
patient
human
metapneumoviru
sar
patient
cohort
coinfect
human
metapneumoviru
mostli
healthcar
worker
ward
share
rest
area
circul
infect
among
sar
outbreak
probabl
explain
frequenc
infect
cohort
similarli
four
sar
patient
canada
infect
sarscov
human
metapneumoviru
clinic
symptom
human
metapneumoviru
infect
vari
mild
upperrespiratorytract
diseas
sever
bronchiol
pneumonia
possibl
role
human
metapneumoviru
infect
exacerb
sar
remain
assess
altern
diagnos
influenza
occasion
made
among
patient
fit
case
definit
sar
test
neg
sarscov
infect
basi
current
case
definit
therefor
diseas
sarscov
infect
overlap
respiratori
ill
caus
altern
diagnos
like
geograph
area
sar
endem
pulmonari
lesion
sarscovinfect
macaqu
compar
sar
patient
respiratori
coronaviru
infect
sialodacryoaden
viru
infect
rat
n
result
rtpcr
viru
isol
ndnot
done
syncytia
found
commonli
bronchiol
less
frequent
alveolar
duct
alveoli
sarscovinfect
macaqu
syncytia
also
promin
alveoli
sar
patient
base
express
pankeratin
syncytia
histiocyt
origin
macaqu
studi
histiocyt
epitheli
origin
sar
patient
format
syncytia
macaqu
may
induc
sarscov
infect
syncytia
posit
sarscov
immunohistochemistri
spike
protein
coronaviru
induc
cell
cell
fusion
pneumocyt
show
cytomegali
enlarg
nuclei
promin
nucleoli
common
sarscovinfect
macaqu
studi
sar
patient
enlarg
cytolog
atypia
hyperplast
type
pneumocyt
occur
commonli
organis
diffus
alveolar
damag
nonspecif
develop
specif
immunohistochem
test
identifi
sarscov
antigen
histolog
sampl
allow
us
assess
cell
tropism
sarscov
infect
macaqu
express
sarscov
lung
restrict
pneumon
area
localis
cytoplasm
type
pneumocyt
syncytia
infect
type
pneumocyt
coronaviru
confirm
transmiss
electron
microscopi
find
correspond
detect
coronaviruslik
particl
pneumocyt
postmortem
lung
sampl
sar
patient
tropism
respiratori
coronavirus
pig
rat
respiratori
epithelium
occasion
alveolar
macrophag
basi
histolog
chang
sarscov
infect
macaqu
primarili
affect
epithelium
alveoli
bronchiol
time
euthanasia
day
infect
pneumon
area
show
earli
advanc
type
pneumocyt
hyperplasia
indic
repair
alveolar
wall
loss
type
pneumocyt
tempor
sequenc
histolog
chang
correspond
experiment
infect
porcin
respiratori
coronaviru
pig
acut
chang
loss
epithelium
presenc
macrophag
fibrin
airway
lumina
seen
day
infect
advanc
chang
type
pneumocyt
hyperplasia
interstiti
mononuclear
cell
infiltr
seen
day
infect
diffus
alveolar
damag
differ
caus
follow
common
pathway
chronic
chang
macaqu
probabl
would
includ
organis
intraalveolar
exud
result
alveolar
fibrosi
bronchiol
obliteran
seen
sar
patient
die
later
cours
diseas
develop
fibrosi
depend
deposit
fibrin
alveoli
rather
continu
presenc
viru
infect
onset
fibrosi
critic
featur
chronic
diffus
alveolar
damag
lead
loss
alveolar
function
irrevers
respiratori
coronaviru
infect
pig
rat
viral
infect
respiratori
epithelium
maximum
day
infect
longer
measur
day
rapid
disappear
infect
cell
initi
infect
might
explain
sarscov
found
type
pneumocyt
occasion
found
type
pneumocyt
macaqu
also
might
decreas
chanc
detect
sarscov
immunohistochemistri
postmortem
lung
tissu
sar
patient
die
protract
cours
diseas
lymphoid
deplet
splenic
follicl
experiment
infect
macaqu
correspond
seen
sar
patient
pig
infect
porcin
respiratori
coronaviru
base
find
togeth
leucopenia
observ
sar
patient
specul
sarscov
infect
suppress
immun
may
predispos
infect
host
secondari
infect
measl
viru
infect
virolog
examin
clinic
postmortem
sampl
experiment
infect
macaqu
indic
respiratori
tract
import
sourc
viru
probabl
case
human
be
unlik
sar
patient
sarscov
detect
urin
faec
macaqu
although
faec
test
posit
previou
experi
find
may
partli
explain
earli
cutoff
point
experi
day
infect
sarscov
rna
detect
faec
sar
patient
late
convalesc
phase
sporad
detect
rtpcr
sarscov
urinari
bladder
stomach
duodenum
cerebrum
spleen
infect
macaqu
absenc
evid
viral
replicationbas
viru
cultur
immunohistochemistrysuggest
overspil
tissu
exampl
via
blood
isol
sarscov
kidney
one
macaqu
suggest
viral
replic
site
theori
could
confirm
immunohistochemistri
rtpcr
base
nucleoprotein
primer
prove
sensit
exist
rtpcr
base
polymeras
primer
presum
differ
due
gradient
transcript
coronaviru
rna
high
concentr
nucleoprotein
rna
low
concentr
polymeras
rna
collect
result
laboratori
studi
sar
patient
experiment
infect
macaqu
prove
newli
discov
sarscov
primari
causal
agent
sar
base
histopatholog
immunohistochem
analysi
postmortem
tissu
macaqu
sarscov
infect
primarili
affect
epithelium
lower
respiratori
tract
potenti
sever
consequ
respiratori
function
none
declar
kuiken
r
fouchier
particip
joint
plan
coordin
studi
kuiken
wrote
report
supervis
interpret
patholog
immunohistochemistri
electron
microscopi
compon
experiment
infect
r
fouchier
schutten
develop
supervis
assess
rtpcr
sarscov
g
f
rimmelzwaan
g
van
amerongen
plan
carri
infect
experi
van
riel
j
laman
involv
design
execut
assess
immunohistochemistri
test
detect
sarscov
tissu
de
jong
electron
microscopi
detect
sarscov
pneumocyt
g
van
doornum
supervis
virolog
analys
sampl
experiment
infect
k
particip
secretari
laboratori
network
sar
diagnosi
play
substanti
part
initi
studi
e
osterhau
princip
investig
respons
overal
plan
coordin
studi
research
involv
develop
applic
assess
diagnost
test
sampl
sar
patient
combin
berend
niemey
georgina
aron
judith
guldemeest
virolog
assist
rob
van
herwijnen
european
veterinari
laboratori
woerden
purif
biotinyl
primari
antisera
immunohistochemistri
frank
van
der
pann
assist
prepar
figur
contribut
analysi
data
azebi
c
batejat
g
corali
b
crescenzochaign
f
fichenick
gerbaud
v
lorin
c
rousseaux
tardypanit
technic
assist
n
tordo
design
primer
help
discuss
f
freymuth
provid
free
human
